Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Unresponsiveness
100%
Stent Thrombosis
100%
Antiplatelet Therapy
100%
Platelets
33%
Drug-eluting Stent
33%
Coronary Artery Disease
16%
Risk Factors
16%
Therapeutic Strategies
16%
Early Identification
16%
Restenosis
16%
Patient Management
16%
Pathological Examination
16%
Thrombus
16%
Antiplatelet
16%
Non-adherence
16%
Premature Discontinuation
16%
Percutaneous Coronary Intervention
16%
Diagnostic Strategy
16%
Future Therapeutics
16%
Bare Metal Stent
16%
Future Diagnostics
16%
Vulnerable Patients
16%
Repeat Revascularization
16%
Medicine and Dentistry
Antiplatelet
100%
Stent Thrombosis
100%
Platelet
33%
Drug-Eluting Stent
33%
Coronary Artery Disease
16%
Prematurity
16%
Restenosis
16%
Revascularization
16%
Thrombus
16%
Percutaneous Coronary Intervention
16%
Nursing and Health Professions
Stent Thrombosis
100%
Drug Eluting Stent
33%
Economic and Social Development
33%
Platelet
33%
Prematurity
16%
Coronary Artery Disease
16%
Revascularization
16%
Restenosis
16%
Thrombus
16%
Bare Metal Stent
16%
Percutaneous Coronary Intervention
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antiplatelet
100%
Stent Thrombosis
100%
Coronary Artery Disease
16%
Prematurity
16%
Restenosis
16%
Thrombus
16%